QNRX

Conviction 14HealthcareScan · Mon, Aug 10, 2026

QNRX$5.20+8.56%

ResistanceSupportVol 14

Vol MA14 12.99K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Quoin Pharmaceuticals, Ltd.PHARMACEUTICAL PREPARATIONSwww.quoinpharma.com ↗

Price5.20

Change+8.56%

Gap-1.88%

Rel volume0.42×

Avg volume13.37K

Avg $ vol58.82K

SMA 204.39

SMA 504.47

SMA 2008.52

Price vs 50+16.31%

Price vs 200-38.97%

MA stackmixed

50/200 cross—

Supertrendup · 4.04

RSI (14)69

MACD hist0.10

MACD cross—

Stoch %K / %D100 / 90

ADX (14)24

+DI / −DI25 / 12

RSI divergence—

MACD divergence—

ATR %+6.21%

ADR %5.50%

52w high22.30

52w low0.0000

From 52w high-76.68%

Above 52w low—

New 52w highNo

SqueezeFired

Bollinger width21.26%

%B1.37

Donchian pos100.00%

Donchian high5.20

Donchian low3.99

AVWAP (52w high)12.74

vs AVWAP high-59.20%

AVWAP (52w low)12.56

vs AVWAP low-58.58%

OBV trendUp

Chaikin MF (20)0.38

Today vs 20d0.42×

Avg vol (14d)12.99K

Avg vol (20d)13.37K

Avg $ vol (20d)58.82K

Market cap17.44B

RS 3m (vs SPY)-30.50%

RS 6m (vs SPY)-52.86%

RS line new highNo

Trend template1/8

Technical rank42.8

1 week+16.85%

1 month+16.85%

3 months-12.31%

6 months-27.17%

1 year-24.75%

YTD-63.07%

P/E-1103.74

P/B1988.36

P/S—

P/FCF—

EPS—

Div yield—

ROE-180.15%

ROA-100.71%

Debt/Eq—

Current2.87

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-76.34%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value17.44B

Revenue—

Net income-5M

Gross profit—

Free cash flow—

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out2.01M

Employees6

ListedThu, Oct 28, 2021

Free float1.04M

Float %0.0%

Short interest156.28K

Days to cover3.9d

Short volume43.6%

Squeeze score52 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction14 / 100

Pattern quality—

Tech rank42.8 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance5.03

Support3.62

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in QNRX

All disclosures →

No recent disclosed trades by Congress in QNRX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in QNRX

No recent insider (Form 4) filings in QNRX. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in QNRX · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.